These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3578054)

  • 21. Persistent hemodynamic effects without long-term clinical benefits in response to oral piroximone (MDL 19,205) in patients with congestive heart failure.
    Petein M; Levine TB; Cohn JN
    Circulation; 1986 Mar; 73(3 Pt 2):III230-6. PubMed ID: 3510778
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of hydralazine on pressure-volume and stress-volume relations in congestive heart failure secondary to idiopathic dilated cardiomyopathy.
    Smucker ML; Sanford CF; Lipscomb KM
    Am J Cardiol; 1985 Oct; 56(10):690-5. PubMed ID: 4050708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hemodynamic effects of levosimendan in acute myocardial infarction complicated by cardiogenic shock and high systemic vascular resistance.
    Tsagalou EP; Kanakakis J; Anastasiou-Nana MI; Drakos SG; Ntalianis AS; Malliaras K; Lazaris N; Katsaros F; Nanas JN
    Acute Card Care; 2009; 11(2):99-106. PubMed ID: 19353405
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute effects of digoxin on total systemic vascular resistance in congestive heart failure due to dilated cardiomyopathy: a hemodynamic-hormonal study.
    Ribner HS; Plucinski DA; Hsieh AM; Bresnahan D; Molteni A; Askenazi J; Lesch M
    Am J Cardiol; 1985 Nov; 56(13):896-904. PubMed ID: 3904388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemodynamic correlates of left ventricular versus right ventricular radionuclide volumetric responses to vasodilator therapy in congestive heart failure secondary to ischemic or dilated cardiomyopathy.
    Konstam MA; Weiland DS; Conlon TP; Martin TT; Cohen SR; Eichhorn EJ; Isner JM; Zile MR; Salem DN
    Am J Cardiol; 1987 May; 59(12):1131-7. PubMed ID: 3578055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of intravenous amrinone and dobutamine in congestive heart failure due to idiopathic dilated cardiomyopathy.
    Marcus RH; Raw K; Patel J; Mitha A; Sareli P
    Am J Cardiol; 1990 Nov; 66(15):1107-12. PubMed ID: 2220638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute hemodynamic effect of oral nifedipine in severe chronic congestive heart failure.
    Elkayam U; Weber L; Torkan B; Berman D; Rahimtoola SH
    Am J Cardiol; 1983 Nov; 52(8):1041-5. PubMed ID: 6637820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Acute changes in the hemodynamic profile and circulating levels of atrial natriuretic peptide induced by dobutamine in severe heart failure].
    La Vecchia L; Bottero M; Centofante P; Bedogni F; Ometto R; Cera A; Fortunato A
    G Ital Cardiol; 1996 Aug; 26(8):863-74. PubMed ID: 9005168
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics and pharmacodynamics of enantiomers of pimobendan in patients with dilated cardiomyopathy and congestive heart failure after single and repeated oral dosing.
    Chu KM; Shieh SM; Hu OY
    Clin Pharmacol Ther; 1995 Jun; 57(6):610-21. PubMed ID: 7781260
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isosorbide dinitrate for the relief of severe heart failure after myocardial infarction.
    Mantle JA; Russell RO; Moraski RE; Rackley CE
    Am J Cardiol; 1976 Feb; 37(2):263-8. PubMed ID: 1108634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sustained benefits or oral pentaerythritol tetranitrate on ventricular function in chronic congestive heart failure.
    Shellock FG; Shah PK; Berman DS; Rubin SA; Singh BN; Swan HJ
    Clin Pharmacol Ther; 1980 Oct; 28(4):436-40. PubMed ID: 7408403
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hemodynamic advantage of combined administration of oral ibopamine and nitroprusside in patients with ischemic and idiopathic congestive cardiomyopathy.
    Dei Cas L; Fappani A; Riva S; Metra M; Cicogna R; Manca C; Visioli O
    Clin Cardiol; 1985 Aug; 8(8):427-32. PubMed ID: 4028536
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute hemodynamic effects of intravenous sildenafil citrate in congestive heart failure: comparison of phosphodiesterase type-3 and -5 inhibition.
    Botha P; Parry G; Dark JH; Macgowan GA
    J Heart Lung Transplant; 2009 Jul; 28(7):676-82. PubMed ID: 19560695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pimobendane (UD-CG 115 BS) in chronic congestive heart failure. Short-term and one-month effects of a new inotropic vasodilating agent.
    Renard M; Walter M; Liebens I; Dresse A; Bernard R
    Chest; 1988 Jun; 93(6):1159-64. PubMed ID: 3371093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Failure of low doses of amrinone to produce sustained hemodynamic improvement in patients with severe chronic congestive heart failure.
    Packer M; Medina N; Yushak M
    Am J Cardiol; 1984 Nov; 54(8):1025-9. PubMed ID: 6496324
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Levosimendan improves hemodynamic status in critically ill patients with severe aortic stenosis and left ventricular dysfunction: an interventional study.
    García-González MJ; Jorge-Pérez P; Jiménez-Sosa A; Acea AB; Lacalzada Almeida JB; Ferrer Hita JJ
    Cardiovasc Ther; 2015 Aug; 33(4):193-9. PubMed ID: 25959786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute hemodynamic effects of the prostacyclin analog 15AU81 in severe congestive heart failure.
    Patterson JH; Adams KF; Gheorghiade M; Bourge RC; Sueta CA; Clarke SW; Jankowski JP; Shaffer CL; McKinnis RA
    Am J Cardiol; 1995 Jan; 75(3):26A-33A. PubMed ID: 7840051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hemodynamic assessment of oral peripheral vasodilator therapy in chronic congestive heart failure: prolonged effectiveness of isosorbide dinitrate.
    Williams DO; Bommer WJ; Miller RR; Amsterdam EA; Mason DT
    Am J Cardiol; 1977 Jan; 39(1):84-90. PubMed ID: 318795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sustained beneficial hemodynamic responses to large doses of transdermal nitroglycerin in congestive heart failure and comparison with intravenous nitroglycerin.
    Rajfer SI; Demma FJ; Goldberg LI
    Am J Cardiol; 1984 Jul; 54(1):120-5. PubMed ID: 6430054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The acute, chronic continuous after treatment and chronic intermittent with a variable therapeutic window (4 and 6 hours) hemodynamic effects induced with transdermal nitroglycerin in patients with congestive heart failure].
    Nodari S; Metra M; Gei P; Danesi R; Furloni R; Cuminetti S; Dei Cas L
    Cardiologia; 1991 Jun; 36(6):451-60. PubMed ID: 1769029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.